Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study

R. Vanna, C. Tresoldi, Aufrid T.M. Lenferink, P. Ronchi, C. Morasso, D. Mehn, M. Bedoni, C. Pignatari, Leonardus Wendelinus Mathias Marie Terstappen, F. Ciceri, Cornelis Otto, F. Gramatica

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

Abstract

Acute myeloid leukemia (AML) is a proliferative neoplasm, that if not properly treated can rapidly cause a fatal outcome. The diagnosis of AML is challenging and the first diagnostic step is the count of the percentage of blasts (immature cells) in bone marrow and blood sample, and their morphological characterization. This evaluation is still performed manually with a bright field light microscope. Here we report results of a study applying Raman spectroscopy for analysis of samples from two patients affected by two AML subtypes characterized by a different maturation stage in the neutrophilic lineage. Ten representative cells per sample were selected and analyzed with high-resolution confocal Raman microscopy by scanning 64x64 (4096) points in a confocal layer through the volume of the whole cell. The average spectrum of each cell was then used to obtain a highly reproducible mean fingerprint of the two different AML subtypes. We demonstrate that Raman spectroscopy efficiently distinguishes these different AML subtypes. The molecular interpretation of the substantial differences between the subtypes is related to granulocytic enzymes (e.g. myeloperoxidase and cytochrome b558), in agreement with different stages of maturation of the two considered AML subtypes . These results are promising for the development of a new, objective, automated and label-free Raman based methods for the diagnosis and first assessment of AML. © (2014) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Original languageEnglish
Title of host publicationBiomedical Vibrational Spectroscopy VI: Advances in Research and Industry
PublisherSPIE
Pages89390F/1-89390F/10
DOIs
Publication statusPublished - 1 Feb 2014

Publication series

NameProceedings of SPIE
PublisherSPIE
Volume8939
ISSN (Print)0277-786X

Fingerprint

Raman Spectrum Analysis
Acute Myeloid Leukemia
Fatal Outcome
Dermatoglyphics
Cell Size
Confocal Microscopy
Bone Marrow Cells
Peroxidase
Light
Enzymes
Neoplasms

Keywords

  • METIS-306216
  • IR-96474

Cite this

Vanna, R., Tresoldi, C., Lenferink, A. T. M., Ronchi, P., Morasso, C., Mehn, D., ... Gramatica, F. (2014). Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study. In Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry (pp. 89390F/1-89390F/10). (Proceedings of SPIE; Vol. 8939). SPIE. https://doi.org/10.1117/12.2039186
Vanna, R. ; Tresoldi, C. ; Lenferink, Aufrid T.M. ; Ronchi, P. ; Morasso, C. ; Mehn, D. ; Bedoni, M. ; Pignatari, C. ; Terstappen, Leonardus Wendelinus Mathias Marie ; Ciceri, F. ; Otto, Cornelis ; Gramatica, F. / Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study. Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry. SPIE, 2014. pp. 89390F/1-89390F/10 (Proceedings of SPIE).
@inproceedings{4166fae976e94c8091e35cddf4070b6c,
title = "Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study",
abstract = "Acute myeloid leukemia (AML) is a proliferative neoplasm, that if not properly treated can rapidly cause a fatal outcome. The diagnosis of AML is challenging and the first diagnostic step is the count of the percentage of blasts (immature cells) in bone marrow and blood sample, and their morphological characterization. This evaluation is still performed manually with a bright field light microscope. Here we report results of a study applying Raman spectroscopy for analysis of samples from two patients affected by two AML subtypes characterized by a different maturation stage in the neutrophilic lineage. Ten representative cells per sample were selected and analyzed with high-resolution confocal Raman microscopy by scanning 64x64 (4096) points in a confocal layer through the volume of the whole cell. The average spectrum of each cell was then used to obtain a highly reproducible mean fingerprint of the two different AML subtypes. We demonstrate that Raman spectroscopy efficiently distinguishes these different AML subtypes. The molecular interpretation of the substantial differences between the subtypes is related to granulocytic enzymes (e.g. myeloperoxidase and cytochrome b558), in agreement with different stages of maturation of the two considered AML subtypes . These results are promising for the development of a new, objective, automated and label-free Raman based methods for the diagnosis and first assessment of AML. {\circledC} (2014) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.",
keywords = "METIS-306216, IR-96474",
author = "R. Vanna and C. Tresoldi and Lenferink, {Aufrid T.M.} and P. Ronchi and C. Morasso and D. Mehn and M. Bedoni and C. Pignatari and Terstappen, {Leonardus Wendelinus Mathias Marie} and F. Ciceri and Cornelis Otto and F. Gramatica",
year = "2014",
month = "2",
day = "1",
doi = "10.1117/12.2039186",
language = "English",
series = "Proceedings of SPIE",
publisher = "SPIE",
pages = "89390F/1--89390F/10",
booktitle = "Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry",
address = "United States",

}

Vanna, R, Tresoldi, C, Lenferink, ATM, Ronchi, P, Morasso, C, Mehn, D, Bedoni, M, Pignatari, C, Terstappen, LWMM, Ciceri, F, Otto, C & Gramatica, F 2014, Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study. in Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry. Proceedings of SPIE, vol. 8939, SPIE, pp. 89390F/1-89390F/10. https://doi.org/10.1117/12.2039186

Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study. / Vanna, R.; Tresoldi, C.; Lenferink, Aufrid T.M.; Ronchi, P.; Morasso, C.; Mehn, D.; Bedoni, M.; Pignatari, C.; Terstappen, Leonardus Wendelinus Mathias Marie; Ciceri, F.; Otto, Cornelis; Gramatica, F.

Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry. SPIE, 2014. p. 89390F/1-89390F/10 (Proceedings of SPIE; Vol. 8939).

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

TY - GEN

T1 - Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study

AU - Vanna, R.

AU - Tresoldi, C.

AU - Lenferink, Aufrid T.M.

AU - Ronchi, P.

AU - Morasso, C.

AU - Mehn, D.

AU - Bedoni, M.

AU - Pignatari, C.

AU - Terstappen, Leonardus Wendelinus Mathias Marie

AU - Ciceri, F.

AU - Otto, Cornelis

AU - Gramatica, F.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Acute myeloid leukemia (AML) is a proliferative neoplasm, that if not properly treated can rapidly cause a fatal outcome. The diagnosis of AML is challenging and the first diagnostic step is the count of the percentage of blasts (immature cells) in bone marrow and blood sample, and their morphological characterization. This evaluation is still performed manually with a bright field light microscope. Here we report results of a study applying Raman spectroscopy for analysis of samples from two patients affected by two AML subtypes characterized by a different maturation stage in the neutrophilic lineage. Ten representative cells per sample were selected and analyzed with high-resolution confocal Raman microscopy by scanning 64x64 (4096) points in a confocal layer through the volume of the whole cell. The average spectrum of each cell was then used to obtain a highly reproducible mean fingerprint of the two different AML subtypes. We demonstrate that Raman spectroscopy efficiently distinguishes these different AML subtypes. The molecular interpretation of the substantial differences between the subtypes is related to granulocytic enzymes (e.g. myeloperoxidase and cytochrome b558), in agreement with different stages of maturation of the two considered AML subtypes . These results are promising for the development of a new, objective, automated and label-free Raman based methods for the diagnosis and first assessment of AML. © (2014) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.

AB - Acute myeloid leukemia (AML) is a proliferative neoplasm, that if not properly treated can rapidly cause a fatal outcome. The diagnosis of AML is challenging and the first diagnostic step is the count of the percentage of blasts (immature cells) in bone marrow and blood sample, and their morphological characterization. This evaluation is still performed manually with a bright field light microscope. Here we report results of a study applying Raman spectroscopy for analysis of samples from two patients affected by two AML subtypes characterized by a different maturation stage in the neutrophilic lineage. Ten representative cells per sample were selected and analyzed with high-resolution confocal Raman microscopy by scanning 64x64 (4096) points in a confocal layer through the volume of the whole cell. The average spectrum of each cell was then used to obtain a highly reproducible mean fingerprint of the two different AML subtypes. We demonstrate that Raman spectroscopy efficiently distinguishes these different AML subtypes. The molecular interpretation of the substantial differences between the subtypes is related to granulocytic enzymes (e.g. myeloperoxidase and cytochrome b558), in agreement with different stages of maturation of the two considered AML subtypes . These results are promising for the development of a new, objective, automated and label-free Raman based methods for the diagnosis and first assessment of AML. © (2014) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.

KW - METIS-306216

KW - IR-96474

U2 - 10.1117/12.2039186

DO - 10.1117/12.2039186

M3 - Conference contribution

T3 - Proceedings of SPIE

SP - 89390F/1-89390F/10

BT - Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry

PB - SPIE

ER -

Vanna R, Tresoldi C, Lenferink ATM, Ronchi P, Morasso C, Mehn D et al. Raman spectroscopy for the assessment of acute myeloid leukemia: a proof of concept study. In Biomedical Vibrational Spectroscopy VI: Advances in Research and Industry. SPIE. 2014. p. 89390F/1-89390F/10. (Proceedings of SPIE). https://doi.org/10.1117/12.2039186